Glenmark launches drug to treat patients with insulin-resistant diabetes
NEW DELHI: Glenmark Pharmaceuticals on Thursday said it has launched Thiazolidinedione Lobeglitazone in the country for the treatment of type...
NEW DELHI: Glenmark Pharmaceuticals on Thursday said it has launched Thiazolidinedione Lobeglitazone in the country for the treatment of type...
NEW DELHI: Arogya World is thrilled to be selected as a recipient of the 2022 UN Interagency Task Force and...